Filing Details
- Accession Number:
- 0001127602-13-008886
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-04 09:21:59
- Reporting Period:
- 2013-02-28
- Filing Date:
- 2013-03-04
- Accepted Time:
- 2013-03-04 09:21:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1100682 | Charles River Laboratories International Inc | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1199985 | Jorg Geller | 251 Ballardvale Street Wilmington MA 01887 | Corporate Executive Vp | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-02-28 | 2 | $40.95 | 57,395 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-02-28 | 100 | $40.39 | 57,295 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-02-28 | 100 | $40.62 | 57,195 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-02-28 | 100 | $40.82 | 57,095 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-02-28 | 100 | $40.59 | 56,995 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-02-28 | 100 | $40.65 | 56,895 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-02-28 | 110 | $40.93 | 56,785 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-02-28 | 100 | $40.94 | 56,685 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-02-28 | 100 | $40.85 | 56,585 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- This sale occurred pursuant to a 10b5-1 Trading Plan.